A variant CD30 protein lacking extracellular and transmembrane domains is induced in HL-60 by tetradecanoylphorbol acetate and is expressed in alveolar macrophages

Blood

Volumn 88, Issue 7, 1996, Pages 2422-2432

  Horie, Ryouichi ^b   Ito, Kinji ^b   Tatewaki, Makoto ^b   Nagai, Masae ^b   Aizawa, Shigemi ^b   Higashihara, Masaaki ^b   Ishida, Takaomi ^b   Inoue, Junichiro ^b   Takizawa, Hajime ^b   Watanabe, Toshiki ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD30 ANTIGEN; PHORBOL 13 ACETATE 12 MYRISTATE;

ALTERNATIVE RNA SPLICING; ANTIBODY DETECTION; ANTIGEN RECOGNITION; ARTICLE; CELL STRAIN HL 60; CROSS LINKING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS MACROPHAGE; MYELOID LEUKEMIA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; REED STERNBERG CELL; RNA TRANSLATION;

EID: 10144248976     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.7.2422.bloodjournal8872422     Document Type: Article

References (34)

1. Falini B, Pileri S, Pizzolo G, Dürkop H, Flenghi L, Stirpe F, Martelli MF, Stein H: CD30 (Ki-1) molecule: A new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy. Blood 85:1, 1995
2. Dürkop H, Latza U, Hummel M, Eitelbach F, Seed B, Stein H: Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell 68:421, 1992
3. Smith CA, Farrah T, Goodwin RG: The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 76:959, 1994
4. Nawrocki JF, Kirstein ES, Fisher RI: Biochemical and structural properties of a Hodgkin's disease-related membrane protein. J Immunol 141:672, 1988
5. Smith CA, Gruss HJ, Davis T, Anderson D, Farah T, Baker E, Sutherland GR, Branann CI, Copeland NG, Jenkins NA, Grabstein KH, Gliniak B, McAlister IB, Fanslow W, Alderson M, Falk B, Gimpel S, Gillis S, Din WS, Goodwin RG, Armitage RJ: CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell 73:1349, 1993
6. Gruss HJ, Boiani N, Williams DE, Armitage RJ, Smith CA, Goodwin RG: Pleiotropic effects of the CD30 ligand in CD30-expressing cells and lymphoma cell lines. Blood 83:2045, 1994
7. Ellis TM, Simms PE, Slivnick DJ, Jäck H-M, Fisher RI: CD30 is a signal-transducing molecule that defines a subset of human activated CD45RO+ T cells. J Immunol 151:2380, 1993
8. Biswas P, Smith CA, Goletti D, Hardy EC, Jackson RW, Fauci AS: Cross-linking of CD30 induces HIV expression in chronically infected T cells. Immunity 2:587, 1995
9. + T cells from HIV-infected individuals. Immunity 3:251, 1995
10. Werner S, Duan D-SR, de Vries C, Peters KG, Johnson DE, Williams LT: Differential splicing in the extracellular region of fibroblast growth factor receptor 1 generates receptor variants with different ligand-binding specificities. Mol Cell Biol 12:82, 1992
11. Miki T, Bottaro DP, Fleming TP, Smith C, Burgess WH, Chan AM-L, Aaronson SA: Determination of ligand-binding specificity by alternative splicing: Two distinct growth factor receptors encoded by a single gene. Proc Natl Acad Sci USA 89:246, 1992
12. Vu TH, Martin GR, Lee P, Mark D, Wang A, Williams LT: Developmentally regulated use of alternative promoters create a novel platelet-derived growth factor receptor transcript in mouse teratocarcinoma and embryonic stem cells. Mol Cell Biol 9:4563, 1989
13. Rossi P, Marziali G, Albanesi C, Charlesworth A, Geremia R. Sorrentino V: A novel c-kit transcript, potentially encoding a truncated receptor, originates within a kit gene intron in mouse spermatids. Dev Biol 152:203, 1992
14. Mosselman S, Claesson-Welsh L, Kamphuis JS, van Zoelen EJJ: Developmentally regulated expression of two novel plateletderived growth factor a-receptor transcripts in human teratocarcinoma cells. Cancer Res 54:220, 1994
15. Flickinger TW, Maihle NJ, Kung H-J: An alternatively processed mRNA from the avian c-erbB gene encodes a soluble, truncated form of the receptor that can block ligand-dependent transformation. Mol Cell Biol 12:883, 1992
16. Raines MA, Liu L, Quan SG, Joe V, DiPersio JF, Golde DW: Identification and molecular cloning of a soluble human granulocytemacrophage colony-stimulating factor receptor. Proc Natl Acad Sci USA 88:8203, 1991
17. Cheng J, Zhou T, Liu C, Shapiro JP, Brauer MJ, Kiefer MC, Barr PJ, Mountz JD: Protection from Fas-meditated apoptosis by a soluble form of the Fas molecule. Science 263:1759, 1995
18. Maruyama K, Sugano S: Oligo-capping: A simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides. Gene 138:171, 1994
19. Tatewaki M, Yamaguchi K, Matsuoka M, Ishii T, Miyasaka M, Mori S, Takatsuki K, Watanabe T: Constitutive overexpression of the L-selectin gene in fresh leukemic cells of adult T-cell leukemia that can be transactivated by human T-cell lymphotropic virus type 1 Tax. Blood 86:3109, 1995
20. Inoue J, Kerr LD, Ransone LJ, Bengal E, Hunter T, Verma IM: c-rel activates but v-rel suppresses transcription from kB sites. Proc Natl Acad Sci USA 88:3715, 1991
21. Neumann JR, Morency CA, Russian KO: A novel rapid assay for chloramphenicol acetyltransferase gene expression. BioTechniques 5:444, 1987
22. Herbomel P, Bourachot B, Yaniv M: Two distinct enhancers with different cell specificities coexist in the regulatory region of polyoma. Cell 39:653, 1984
23. Zimber A, Chedeville A, Gespach C, Abita J-P: Inhibition of proliferation and induction of monocytic differentiation in HL60 human promyelocytic leukemia cells treated with bile acids in vitro. Int J Cancer 59:71, 1994
24. Tabilio A, Pelicci PG, Mannoni P, Civin CI, Vainchenker W, Testa U, Lipinski M, Rochant H, Breton-Gorius J: Myeloid and megakaryocytic properties of K-562 cell lines. Cancer Res 43:4569, 1983
25. Malden LT, Novak U, Kaye AH, Burgess AW: Selective amplification of the cytoplasmic domain of the epidermal growth factor receptor gene in glioblastoma multiforme. Cancer Res 48:2711, 1988
26. Sugawa N, Ekstrand AJ, James CD, Collins VP: Identical splicing of aberrant growth factor receptor transcripts from amplified rearranged genes in human glioblastomas. Proc Natl Acad Sci USA 87:8602, 1990
27. Andreesen R, Osterholz J, Lohr GW, Bross KJ: A Hodgkin cell-specific antigen is expressed on a subset of auto- and alloactivated T (helper) lymphoblasts. Blood 63:1299, 1984
28. Schwarting R, Gerdes J, Dürkop H, Falini B, Pileri S, Stein H: Ber-H2: A new anti-Ki-1 (CD30) monoclonal antibody directed at a formol-resistant epitope. Blood 74:1678, 1989
29. Aizawa S, Satoh H, Horie R, Ito K, Choi SH, Takeuchi H, Watanabe T: Cloning and characterization of a cDNA for rat CD30 homolog and chromosomal assignment of the genomic gene. Gene (in press)
30. Lee SY, Park CG, Choi Y: T cell receptor-dependent cell death of T cell hybridomas mediated by the CD30 cytoplasmic domain in association of tumor necrosis factor receptor-associated proteins. J Exp Med 183:669, 1996
31. Rothe M, Wong SC, Henzel WJ, Goeddel DV: A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 78:681, 1994
32. Hu HM, O'Rourke K, Boguski MS, Dixit VM: A novel RING finger protein interacts with the cytoplasmic domain of CD40. J Biol Chem 269:30069, 1994
33. Mosialos G, Birkenbach M, Yalamanchili R, VanArsdale T, Ware C. Kieff E: The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80:389, 1995
34. Cheng G, Cleary AM, Ye Z-S, Hong DI, Lederman S, Baltimore D: Involvement of CRAF-1, relative of TRAF, in CD40 signaling. Science 267:1494, 1995